Neha Krishnamohan
Director/Board Member at ARCUTIS BIOTHERAPEUTICS, INC.
Net worth: 48 164 $ as of 2024-04-29
Neha Krishnamohan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Director/Board Member | 2022-09-01 | - |
| Independent Dir/Board Member | 2022-09-01 | - |
Career history of Neha Krishnamohan
Former positions of Neha Krishnamohan
| Companies | Position | Start | End |
|---|---|---|---|
| KINNATE BIOPHARMA INC. | Director of Finance/CFO | 2021-06-06 | 2024-04-02 |
| THE GOLDMAN SACHS GROUP, INC. | Corporate Officer/Principal | 2008-06-30 | 2021-04-30 |
Training of Neha Krishnamohan
| Duke University | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Director of Finance/CFO | 1 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| THE GOLDMAN SACHS GROUP, INC. | Finance |
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Neha Krishnamohan
- Experience
